Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us S.Y. (Sanne) Smith-Apeldoorn
University Medical Center Groningen

S.Y. (Sanne) Smith-Apeldoorn

No picture available
E-mail:
s.y.apeldoorn umcg.nl

Publications

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach

Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial

The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study

Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients with Treatment-Resistant Depression: A Case Series

Oral esketamine for difficult-to-treat depression

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program

Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment

Press/media

‘Geef selecte groep depressiepatiënten langdurig ketamine’

‘Geef selecte groep depressiepatiënten langdurig ketamine’

Sustainable Development Goals

SDG 3 - Good Health and Well-being

More information about the Sustainable Development Goals.